[1] Aggarwal RS. What’s fueling the biotech engine-2012 to 2013[J]. Nat Biotechnol, 2014, 32:32-39. [2] Liu H, Gaza-Bulseco G, Faldu D, et al. Heterogeneity of monoclonal antibodies[J]. J Pharm Sci, 2008, 97(7):2426-2447. [3] Van den Bremer ET, Beurskens FJ, Voorhorst M, et al. Human IgG is produced in a pro-form that requires clipping of C-terminal lysines for maximal complement activation[J]. MAbs, 2015, 7(4):672-680. [4] Eon-Duval A, Broly H, Gleixner R. Quality attributes of recombinant therapeutic proteins:an assessment of impact on safety and efficacy as part of a quality by design development approach[J]. Biotechnol Prog, 2012, 28(3):608-622. [5] Luo J, Vijayasankaran N, Autsen J, et al. Comparative metabolite analysis to understand lactate metabolism shift in Chinese hamster ovary cell culture process[J]. Biotechnol Bioeng, 2012, 109(1):146-156. [6] Chaderjian WB, Chin ET, Harris RJ, et al. Effect of copper sulfate on performance of a Serum-Free CHO Cell culture process and the level of free thiol in the recombinant antibody expressed[J]. Biotechnol Prog, 2005, 21(2):550-553. [7] Kao YH, Hewitt DP, Trexler-Schmidt M, et al. Mechanism of antibody reduction in cell culture production processes[J]. Biotechnol Bioeng, 2010, 107(4):622-632. [8] Surve T, Gadgil M. Manganese increases high mannose glycoform on monoclonal antibody expressed in CHO when glucose is absent or limiting:Implications for use of alternate sugars[J]. Biotechnol Prog, 2015, 31(2):460-467. [9] Kaschak T, Boyd D, Lu F, et al. Characterization of the basic charge variants of a human IgG1:effect of copper concentration in cell culture media[J]. MAbs, 2011, 3(6):577-583. [10] Yang JD, Lu C, Stasny B, et al. Fed-batch bioreactor process scale-up from 3-L to 2500-L scale for monoclonal antibody production form cell culture[J]. Biotechnol Bioeng, 2007, 98(1):141-154. [11] Zhang X, Tang H, Sun YT, et al. Elucidating the effects of arginine and lysine on a monoclonal antibody C-terminal lysine variation in CHO cell cultures[J]. Appl Microbiol Biotechnol, 2015, 99(16):6643-6652. [12] Yuk IH, Russell S, Tang Y, et al. Effects of copper on CHO cells:cellular requirements and product quality considerations[J]. Biotechnol Prog, 2015, 31(1):226-238. [13] Kim BG, Park HW. High zinc ion supplementation of more than 30 muM can increase monoclonal antibody production in recombinant Chinese hamster ovary DG44 cell culture[J]. Appl Microbiol Biotechnol, 2016, 100(5):2163-2170. [14] Wong VV, Ho KW, Yap MG. Evaluation of insulin-mimetic trace metals as insulin replacements in mammalian cell cultures[J]. Cytotechnology, 2004, 45(3):107-115. [15] Cao H. Expression, purification, and biochemical characterization of the antiinflammatory tristetraprolin:a zinc-dependent mRNA binding protein affected by posttranslational modifications[J]. Biochemistry, 2004, 43(43):13724-13738. [16] Zhang X, Sun YT, Tang H, et al. Culture temperature modulates monoclonal antibody charge variation distribution in Chinese hamster ovary cell cultures[J]. Biotechnol Lett, 2015, 37(11):2151-2157. [17] 吴珊, 李素霞. 重组猪羧肽酶B的酶学性质及稳定性研究[J]. 食品与药品, 2012, 14(5):159-162. [18] Hossler P, Wang M, McDermott S, et al. Cell culture media supplementation of bioflavonoids for the targeted reduction of acidic species charge variants on recombinant therapeutic proteins[J]. Biotechnol Prog, 2015, 31(4):1039-1052. [19] Du Y, Walsh A, Ehrick R, et al. Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies[J]. MAbs, 2012, 4(5):578-585. |